• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis

Sestito, C.

2019

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Sestito, C. (2019). Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis: Implications

for the pathogenesis and clinical outcome.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

Blood cell-derived human tissue

Transglutaminase (TG2) in multiple sclerosis

Implications for the pathogenesis and clinical outcome

(3)

Title: Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis - Implications for the pathogenesis and clinical

outcome

-Author: Claudia Sestito

Cover front: Design Credits: vecteezy.com

Cover back: Image from shutterstock - resembling TG2 molecular structure in an open conformation

Lay Out: Jasper Koning Printed by: Ipskamp Printing ISBN: 978-94-028-1643-3

Copyright © 2019, Claudia Sestito. All right reserved. No part of this publication may be reproduced, stored or transmitted in any form of by any means, without prior permission from the author.

The author and the research presented in this thesis were financially supported by the European Union’s Seventh Framework Program FP7 “TRANSPATH” (grant nr 289964) and the Dutch Multiple Sclerosis (MS) Research foundation (grant nr MS14-865).

(4)

VRIJE UNIVERSITEIT

Blood cell-derived human tissue

Transglutaminase (TG2) in multiple sclerosis

Implications for the pathogenesis and clinical outcome

-ACADEMISCH PROEFSCHRIFT

ter verkrijging van de graad Doctor aan

de Vrije Universiteit Amsterdam,

op gezag van de rector magnificus

prof.dr. V. Subramaniam,

in het openbaar te verdedigen

ten overstaan van de promotiecommissie

van de Faculteit der Geneeskunde

op donderdag 31 oktober 2019 om 9.45 uur

in de aula van de universiteit,

De Boelelaan 1105

door

Claudia Sestito

(5)

promotor: dr. B. Drukarch copromotoren: dr. A.M.W. van Dam

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was financially supported by the project grant H2020-MSCA- RISE grant number 644373 – PRISAR, the European Union Seventh Framework Program

The work presented in this thesis was financially supported by the Netherlands Organization for Scientific Research NWO Innovational Research Incentives (grant number 917.56.356)....

This work was supported by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement 278367 (EMTICS);

The research leading to the results presented in this thesis has received funding from The European Community’s Seventh Framework Programme FP7, Centre for Medical Systems

The research described in this thesis was performed at the department of Urology of Leiden University Medical Center and was financially supported by the FP7 Marie Curie ITN grant

To capture the effects of the Single European Market (SEM) Program, two indicators taken from the Cecchini Report (1988) were added for sectors having high non-tariff barriers at

The research was financially supported by the European Research Council, the European Union Seventh Framework Programme, Top Institute (TI) Pharma, the

The research presented in this thesis was financially supported by the Abel Tasman talented Program, University of Groningen and by the Department of Obstetrics and Gynaecology of